Loading...
Loading...
India's diazepam imports from UNITED STATES total $1.5M across 59 shipments from 14 foreign suppliers. RISE PHARMA LLC leads with $1.2M in import value; the top 5 suppliers together control 97.7% of this origin. Leading Indian buyers include ZYDUS LIFESCIENCES LIMITED. This corridor reflects India's pharmaceutical import demand for diazepam — a diversified sourcing base with multiple active suppliers from UNITED STATES.

RISE PHARMA LLC is the leading Diazepam supplier from UNITED STATES to India, with import value of $1.2M across 22 shipments. The top 5 suppliers — RISE PHARMA LLC, Globyz Pharma LLC, GLOBYZ PHARMA LLC, NOVEL LABORATORIES INC, Rise Pharma LLC — collectively account for 97.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RISE PHARMA LLC | $1.2M | 22 | 84.1% |
| 2 | Globyz Pharma LLC | $79.0K | 2 | 5.4% |
| 3 | GLOBYZ PHARMA LLC | $56.3K | 1 | 3.9% |
| 4 | NOVEL LABORATORIES INC | $40.7K | 13 | 2.8% |
| 5 | Rise Pharma LLC | $22.5K | 5 | 1.5% |
| 6 | AUCTA PHARMACEUTICALS | $19.9K | 2 | 1.4% |
| 7 | RISE PHARMA | $7.9K | 2 | 0.5% |
| 8 | MSUNITED STATES PHARMACOPEIAL CONVENTION | $1.8K | 1 | 0.1% |
| 9 | M/S.R&H PHARMACY INC | $1.7K | 1 | 0.1% |
| 10 | STRIDES PHARMA INC | $591 | 1 | 0.0% |
| 11 | AACE PHARMACEUTICALS, INC | $371 | 4 | 0.0% |
| 12 | NAVINTA LLC | $325 | 2 | 0.0% |
| 13 | HIKMA PHARMACEUTICALS INC | $145 | 1 | 0.0% |
| 14 | BELOTECA INC | $67 | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $1.1M | 8 | 72.7% |
| 2 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $148.3K | 5 | 10.2% |
| 3 | LUPIN LIMITED | $129.3K | 15 | 8.9% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED | $47.2K | 4 | 3.2% |
| 5 | VEEDA CLINICAL RESEARCH LIMITED | $20.2K | 3 | 1.4% |
| 6 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED | $12.6K | 3 | 0.9% |
| 7 | HETERO LABS LIMITED | $11.7K | 4 | 0.8% |
| 8 | ALKEM LABORATORIES LIMITED | $11.1K | 2 | 0.8% |
| 9 | CIPLA LIMITED | $8.3K | 2 | 0.6% |
| 10 | CAPLIN STERILES LIMITED | $3.5K | 2 | 0.2% |
| 11 | CLIANTHA RESEARCH LIMITED | $2.5K | 1 | 0.2% |
| 12 | DR.REDDY'S LABORATORIES LTD | $1.1K | 1 | 0.1% |
| 13 | INVITRON ADVANCED ANALYTICS PRIVATE LIMITED | $591 | 1 | 0.0% |
| 14 | VIMTA LABS LIMITED | $516 | 5 | 0.0% |
| 15 | AZIDUS LABORATORIES LIMITED | $67 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Diazepam suppliers from UNITED STATES to India include RISE PHARMA LLC, Globyz Pharma LLC, GLOBYZ PHARMA LLC. The leading supplier is RISE PHARMA LLC with import value of $1.2M USD across 22 shipments. India imported Diazepam worth $1.5M USD from UNITED STATES in total across 59 shipments.
India imported Diazepam worth $1.5M USD from UNITED STATES across 59 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Diazepam sourced from UNITED STATES include ZYDUS LIFESCIENCES LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, LUPIN LIMITED. The largest buyer is ZYDUS LIFESCIENCES LIMITED with $1.1M in imports across 8 shipments.
The total value of Diazepam imports from UNITED STATES to India is $1.5M USD, across 59 shipments and 14 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
59 Verified Shipments
14 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists